Prior to his session, “The Epidemiology of Alopecia Areata & Risk Factors Associated with increased Risk to Develop Alopecia Areata,” to be presented at the Mount Sinai Winter Symposium, Dr Benjamin Ungar discussed the epidemiology of alopecia areata (AA) in the context of a broader symposium covering various aspects of the disease, from pathogenesis to treatments. He also emphasized the importance of understanding the demographics affected by AA, its frequency, and associated medical conditions.

Dr Ungar explained that his session will provide an overview of how common AA is, considering different populations, countries, and methodologies. He aims to paint a comprehensive picture of the age groups and demographics that are more susceptible to AA by shedding light on the prevalence and potential risk factors associated with the condition.

Regarding risk factors, Dr Ungar’s session will delve into bidirectional associations, where certain conditions may increase the likelihood of AA, and vice versa. He highlighted atopic dermatitis as the primary condition that often coexists with AA, along with other atopic conditions like asthma and seasonal allergies. Family history also plays a role, increasing the odds of developing AA. On the flip side, having AA elevates the risk of other conditions, such as thyroid disease and other autoimmune disorders.

Moving on to the challenges and considerations in managing AA, Dr Ungar stressed the misconception of AA as merely a cosmetic concern. He emphasized the profound impact it has on patients and the challenge of ensuring it is treated with the gravity it deserves. Additionally, managing comorbidities like thyroid disease and addressing the holistic well-being of patients present challenges in the clinical approach.

In conclusion, Dr Ungar encouraged colleagues to view AA not just from a medical perspective but also through the lens of patients who are impacted by it. He noted that the symposium provides a unique opportunity to gain insights into the various facets of AA, including epidemiology, comorbidities, pathogenesis, and treatments. The inclusion of patient perspectives is deemed crucial, as it fosters a deeper understanding of the profound impact of AA on individuals' lives.

“Hearing directly from patients,” according to Dr Ungar, “adds a significant dimension to appreciating the challenges and significance of managing alopecia areata.”

Reference
Ungar B. The epidemiology of alopecia areata & risk factors associated with increased risk to develop alopecia areata. Presented at: 26^th Annual Mount Sinai Symposium; November 30-December 3, 2023; New York, NY.